JAGX vs. NBRV, AADI, IMRX, RMTI, CALC, CLNN, APLM, NXTC, BOLT, and BLRX
Should you be buying Jaguar Health stock or one of its competitors? The main competitors of Jaguar Health include Nabriva Therapeutics (NBRV), Aadi Bioscience (AADI), Immuneering (IMRX), Rockwell Medical (RMTI), CalciMedica (CALC), Clene (CLNN), Apollomics (APLM), NextCure (NXTC), Bolt Biotherapeutics (BOLT), and BioLineRx (BLRX). These companies are all part of the "pharmaceutical preparations" industry.
Jaguar Health (NASDAQ:JAGX) and Nabriva Therapeutics (NASDAQ:NBRV) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations, media sentiment, risk and community ranking.
Jaguar Health received 1442 more outperform votes than Nabriva Therapeutics when rated by MarketBeat users. Likewise, 89.21% of users gave Jaguar Health an outperform vote while only 58.48% of users gave Nabriva Therapeutics an outperform vote.
Jaguar Health has higher earnings, but lower revenue than Nabriva Therapeutics.
Nabriva Therapeutics has a net margin of -148.11% compared to Jaguar Health's net margin of -423.11%. Nabriva Therapeutics' return on equity of -365.53% beat Jaguar Health's return on equity.
12.0% of Jaguar Health shares are held by institutional investors. Comparatively, 0.3% of Nabriva Therapeutics shares are held by institutional investors. 0.0% of Jaguar Health shares are held by insiders. Comparatively, 1.6% of Nabriva Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Jaguar Health has a beta of 1.35, indicating that its stock price is 35% more volatile than the S&P 500. Comparatively, Nabriva Therapeutics has a beta of 1.53, indicating that its stock price is 53% more volatile than the S&P 500.
In the previous week, Jaguar Health and Jaguar Health both had 1 articles in the media. Jaguar Health's average media sentiment score of 0.00 equaled Nabriva Therapeutics'average media sentiment score.
Summary
Jaguar Health and Nabriva Therapeutics tied by winning 5 of the 10 factors compared between the two stocks.
Get Jaguar Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for JAGX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding JAGX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Jaguar Health Competitors List
Related Companies and Tools
